Thromboprophylaxis for Intensive Care Patients
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2014, Vol 4, Issue 1
Abstract
The advent of low-molecular-weight heparin (LMWH) marked a new chapter in the prevention of venous thromboembolism. The enviable pharmacokinetic properties associated with this class of medication, ensured the place of LMWH as an attractive, if albeit more expensive alternative to unfractionated heparin. Predictable and reproducible dose response continues to negate the need for monitoring in most patient groups, while the availability of antidotes further boosts the safety profile of LMWH. These agents have long proven their worth in the medico-surgical patient population. However we have recently shown in randomised studies, that LMWH at the current recommended dose may not be as effective for critically ill patients. Critically ill patients encompass that population of patients with profound disturbance of physiology, who are at imminent risk of death and in need of continuous care. Such patients have proven to be somewhat resistant, and current evidence indicates that they may benefit from a higher dose of LMWH. A difficult undertaking, considering the heterogeneity of this population, as well as their predisposition to both haemorrhage and thromboembolism. A variety of new oral antithrombotics has recently become available for use among certain patient populations, but has not yet been studied in the intensive care unit (ICU) setting. These agents have been associated with increased risk of bleeding, and as yet, a definitive strategy in the event of major bleeding does not exist. In addition, they are more costly when compared with LMWH. All the aforementioned factors combine to make the new oral agents, unattractive alternatives for thromboprophylaxis in the ICU population.
Authors and Affiliations
Sian Robinson, Palle Toft
Keywords
Related Articles
- EP ID EP348463
- DOI 10.9734/BJMMR/2014/5553
- Views 113
- Downloads 0
Prevalence of Rotavirus Infection in Infants and Young Children with Gastroenteritis in Two North-East States, Nigeria
Introduction: Rotavirus, is an eleven segmented double stranded ribonucleic acid virus in the family of Reoviridae, and is a leading cause of gastroenteritis among infants and young children. Aims: This study was aimed a...
Risk Factors and Anthropometric Variables of Young People with Essential Hypertension in Uyo, Akwa Ibom State
Hypertension, a chronic medical condition is commonly seen in young people in my environment. Certain risk factors are associated with the development of this condition. They include a positive family history of hyperten...
Pre-hospital Use of Oral Rehydration Therapy and Zinc and the Risk of Dehydration in Childhood Diarrhoea
Background: Diarrhoea is a leading cause of childhood mortality globally. The use of oral rehydration therapy (ORT) with zinc supplementation is recommended in the treatment of childhood diarrhoea. Objective: To determi...
Drug Permeation across the Blood-Brain Barrier: Applications of Nanotechnology
The blood-brain barrier (BBB) is a neurobiological frontier that isolates brain tissues from the blood vascular system. Its main role is to protect the brain and the central nervous system from external fluctuations in h...
Antimicrobial Susceptibility Pattern of Haemophilus influenzae among Under-five Children Presenting at the Emergency Paediatric Unit (EPU) of Two Teaching Hospitals in Jos, Nigeria
Background: Haemophilus influenzae meningitis is a leading cause of endemic bacterial meningitis in infants and under-five children globally. H. influenza infection is severe where vaccine is not routinely used and one-t...